Metraipolis › archive › dc_72b010f15680
Sequential tyrosine kinase inhibitor therapy for EGFR L747P-mutated lung adenocarcinoma in a renal transplant recipient: a 24-month case report — Europe PMC PMID:41133137
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41133137
- DOI
- 10.3389/fmed.2025.1651584
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T12:38:31.981Z
- SHA-256 of the archived text
d3b5545635e198fbcaca0f2676c662d5f65f3969b079e9f0791d9fae149b3b57- Stable URL of this page
https://metraipolis.com/documento/dc_72b010f15680
How to cite
Sequential tyrosine kinase inhibitor therapy for EGFR L747P-mutated lung adenocarcinoma in a renal transplant recipient: a 24-month case report — Europe PMC PMID:41133137 — Europe PMC (en), https://europepmc.org/article/MED/41133137 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72b010f15680 (Metraipolis archive dc_72b010f15680, sha256 d3b5545635e198fbcaca0f2676c662d5f65f3969b079e9f0791d9fae149b3b57)
BibTeX
@misc{dc72b010f15680,
title = {Sequential tyrosine kinase inhibitor therapy for EGFR L747P-mutated lung adenocarcinoma in a renal transplant recipient: a 24-month case report — Europe PMC PMID:41133137},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41133137},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72b010f15680; sha256 d3b5545635e198fbcaca0f2676c662d5f65f3969b079e9f0791d9fae149b3b57},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41133137. Agents can read the archived copy with the MCP tool read_document.